PepGen Inc

For the period ended Mar 31, 2024. Filed May 14, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 14, 2024

PEPG$4.61+92.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity

(IN THOUSANDS, EXCEPT SHARE AMOUNTS)

Common Stock · AdditionalPaid-in · AccumulatedOtherComprehensive(Loss) · Accumulated · TotalStockholders’
	Shares	Amount	Capital	Income	Deficit	Equity
Balance as of December 31, 2023	23,823,241	$2	$289,867	$34	$(181,482)	$108,421
Issuance of stock in public offering, net of underwriters' fees and issuance costs of $3,730	7,530,000	1	76,351	—	—	76,352
Issuance of common stock from At-the-Market Sales Agreement, net of underwriters' fees of $100	1,000,000	—	9,900	—	—	9,900
Exercise of stock options	36,194	—	395	—	—	395
Stock-based compensation expense	—	—	2,022	—	—	2,022
Unrealized loss on marketable securities	—	—	—	(20)	—	(20)
Cumulative translation adjustment arising during the period	—	—	—	(51)	—	(51)
Net loss	—	—	—	—	(18,020)	(18,020)
Balance as of March 31, 2024	32,389,435	$3	$378,535	$(37)	$(199,502)	$178,999
Balance as of December 31, 2022	23,713,196	$2	$282,566	$(81)	$(102,856)	$179,631
Exercise of stock options	68,709	—	130	—	—	130
Stock-based compensation expense	—	—	1,348	—	—	1,348
Cumulative translation adjustment arising during the period	—	—	—	53	—	53
Net loss	—	—	—	—	(16,319)	(16,319)
Balance as of March 31, 2023	23,781,905	$2	$284,044	$(28)	$(119,175)	$164,843

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.